NCT06661486

Brief Summary

The investigators aim to investigate the relationship between lifestyle factors and cognitive decline among older Singaporeans and assess the feasibility and preliminary efficacy of a lifestyle intervention programme in delaying cognitive decline. Healthy lifestyle is a way of living that can lower down disease risk and promote health and wellbeing. Accumulating evidences support that lifestyle factors contribute to the development of dementia and hence modifying lifestyle could be a promising approach for dementia prevention. The intervention will focus on the promotion of a brain-healthy lifestyle, with special attention paid to common problems among local older adults. The investigators will assess cognitive and biological changes using the following outcome measures. Primary outcome: the processing speed domain Z score derived from raw scores of three tests including the symbol digit modality test, Colour trial test, and Stroop test (condition 2). Secondary outcome: i. epigenetic age (DNA methylation), ii. plasma-based markers of inflammation, iii. activities of daily living and instrumental activities of daily living, iv. Health-related quality of life measured by the EQ-5D-5L scale, v. wellbeing measured by the ICECAP-O (ICEpop CAPability measure for Older people), vi. other neurocognitive assessment tests. The investigators hypothesize that:

  1. 1.Lifestyle factors are associated with cognitive decline, epigenetic age, and systematic chronic inflammation.
  2. 2.Evidence-based lifestyle intervention focusing on common problems among local population can delay cognitive decline, slow epigenetic ageing, and produce favorable changes on chronic systemic inflammation.
  3. 3.Changes in biological markers will correlate with changes in cognitive function, and hence partially explains the observed clinical efficacy.
  4. 4.The interventions may also improve daily functioning, health-related quality of life, and wellbeing.
  5. 5.Interventions delivered in an individualized manner would produce more benefits than interventions delivered uniformly without considering individual's risk profile and personal and social context.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
22mo left

Started Oct 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Oct 2024Apr 2028

First Submitted

Initial submission to the registry

June 24, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

October 28, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2028

Expected
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

1.5 years

First QC Date

June 24, 2024

Last Update Submit

April 7, 2026

Conditions

Keywords

Lifestyle InterventionMMSECDR

Outcome Measures

Primary Outcomes (1)

  • Standard Neuropsychological Tests of Information Processing Speed

    The primary outcome of the trial is the processing speed, measured using the average of domain Z score derived from raw scores of three tests including the symbol digit modality test, colour trial test (Condition A) and Stroop test (Condition 2). The average of Z scores standardised to the baseline mean and standard deviation of trial participants, with higher scores representing better processing speed.

    Cognitive assessment will be conducted at three timepoints within 2 years period, baseline, 12 months and 24 months

Secondary Outcomes (17)

  • Biological Outcome

    All of the outcome measures will be measured at three timepoints including baseline, 12 months and 24 months

  • Biological Outcome

    All of the outcome meausures will be measured at three timepoints including baseline, 12 months and 24 months

  • Quality of life Outcome

    All of the outcome measures will be measured at three timepoints including baseline, 12 months and 24 months

  • Quality of life Outcome

    All of the outcome measures will be measured at three timepoints including baseline, 12 months and 24 months

  • Social Support Outcome

    All of the outcome measures will be measured at three timepoints including baseline, 12 months and 24 months

  • +12 more secondary outcomes

Study Arms (3)

Control group

NO INTERVENTION

The control group will not receive any intervention and, is only required to attend 3 timepoints of cognitive assessment: baseline, 12 months and 24 months.

Uniformed intervention group

EXPERIMENTAL

Uniformed intervention groups receive health education sessions in a group setting. Each session is one hour, and lifestyle health-related topics will be delivered to the participants for their knowledge.

Behavioral: Uniformed intervention group

Individualised intervention group

ACTIVE COMPARATOR

The individualised intervention group receives health education sessions as the uniformed intervention group and receives additional one-on-one health coaching, which besides the group sessions, the participants receive individual sessions every three months.

Behavioral: Individualised intervention group

Interventions

The investigators provide lifestyle intervention through a health education programme which is in a group setting. The sessions consisted of short talks on a health-related topic targeting lifestyle factors associated with dementia risk, followed by group activities that required interactions, cognitive engagement, and the acquisition of certain skills (for example, how to read food labels, how to measure blood pressure, how to recognize signs of depression, et al).

Uniformed intervention group

On top of the uniformed intervention group, the individualised intervention group receives also 1:1 sessions every 3 months within 2 years. Participants will review the knowledge taught in the group sessions individually and the investigator will address the participant's concerns and provide advice to the participant for a better lifestyle accordingly.

Individualised intervention group

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (1) Age 60-75 years;
  • (2) Singapore Modified Mini-Mental State Examination total score lower than locally validated education-specific cutoffs: \< 25, 27 and 29 for those with nil, primary and secondary school and above education levels, respectively66.
  • (3) Non-demented (Clinical Dementia Rating global score = 0).

You may not qualify if:

  • Conditions preventing effective engagement in the intervention
  • (1) Terminal illness, aphasia
  • (2) Marked hearing impairment
  • (3) Participation in another interventional study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

National University Singapore, Tahir Foundation Building

Singapore, Singapore, 117549, Singapore

RECRUITING

National University Singapore

Singapore, Singapore, 119228, Singapore

RECRUITING

Related Publications (3)

  • Liu LY, Lu Y, Shen L, Li CB, Yu JT, Yuan CR, Ye KX, Chao YX, Shen QF, Mahendran R, Kua EH, Yu DH, Feng L. Prevalence, risk and protective factors for mild cognitive impairment in a population-based study of Singaporean elderly. J Psychiatr Res. 2022 Jan;145:111-117. doi: 10.1016/j.jpsychires.2021.11.041. Epub 2021 Nov 25.

    PMID: 34894520BACKGROUND
  • Ye KX, Sun L, Wang L, Khoo ALY, Lim KX, Lu G, Yu L, Li C, Maier AB, Feng L. The role of lifestyle factors in cognitive health and dementia in oldest-old: A systematic review. Neurosci Biobehav Rev. 2023 Sep;152:105286. doi: 10.1016/j.neubiorev.2023.105286. Epub 2023 Jun 13.

    PMID: 37321363BACKGROUND
  • Wu DX, Feng L, Yao SQ, Tian XF, Mahendran R, Kua EH. The early dementia prevention programme in Singapore. Lancet Psychiatry. 2014 Jun;1(1):9-11. doi: 10.1016/S2215-0366(14)70233-0. Epub 2014 Jun 4. No abstract available.

    PMID: 26360390BACKGROUND

Central Study Contacts

Kai Xuan Lim, Bachelor Degree in Psy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: the participants will be randomly assigned to one of the three arms, uniformed intervention, individualized intervention or the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 24, 2024

First Posted

October 28, 2024

Study Start

October 1, 2024

Primary Completion

April 1, 2026

Study Completion (Estimated)

April 1, 2028

Last Updated

April 8, 2026

Record last verified: 2026-04

Locations